Comparing adult and pediatric Hodgkin lymphoma in the Surveillance, Epidemiology and End Results Program, 1988–2005: an analysis of 21 734 cases

References

• Arya LS, Dinand V. Current strategies in the treatment of childhood Hodgkin's disease. Indian Pediatr 2005;42:1115–1128.
   PubMed Web of Science ®Google Scholar
• Foltz LM, Song KW, Connors JM. Hodgkin's lymphoma in adolescents. J Clin Oncol 2006;24:2520–2526.
   PubMed Web of Science ®Google Scholar
• Barista I, Varan A, Ozyar E. Bimodal age distribution in Hodgkin's disease and nasopharyngeal carcinoma. Med Hypotheses 2007;68:1421.
   PubMed Web of Science ®Google Scholar
• Grufferman S, Delzell E. Epidemiology of Hodgkin's disease. Epidemiol Rev 1984;6:76–106.
   PubMed Web of Science ®Google Scholar
• Connors JM. Evolving approaches to primary treatment of Hodgkin lymphoma. Hematology Am Soc Hematol Educ Program 2005:239–244.
   PubMedGoogle Scholar
• Chabay PA, Barros MH, Hassan R, et al. Pediatric Hodgkin lymphoma in 2 South American series: a distinctive epidemiologic pattern and lack of association of Epstein-Barr virus with clinical outcome. J Pediatr Hematol Oncol 2008;30:285–291.
   PubMed Web of Science ®Google Scholar
• Clarke CA, Glaser SL, Prehn AW. Age-specific survival after Hodgkin's disease in a population-based cohort (United States). Cancer Causes Control 2001;12:803–812.
   PubMed Web of Science ®Google Scholar
• Hasenclever D, Diehl V, Armitage JO, et al. A prognostic score for advanced Hodgkin's disease. N Engl J Med 1998;339:1506–1514.
   PubMed Web of Science ®Google Scholar
• Nogova L, Reineke T, Brillant C, et al. Lymphocyte-predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin Study Group. J Clin Oncol 2008;26:434–439.
   PubMed Web of Science ®Google Scholar
• Engert A. Treatment of lymphocyte-predominant Hodgkin lymphoma. Ann Oncol 2008;19(Suppl. 4):iv45–iv46.
   PubMedGoogle Scholar
• Illes A, Simon Z, Toth E, Rosta A, Miltenyi Z, Molnar Z. Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL)-clinicopathological features based on the data of two Hungarian lymphoma centres. Pathol Oncol Res 2008;14:411–421.
   PubMed Web of Science ®Google Scholar
• Smith RS, Chen Q, Hudson MM, et al. Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy. J Clin Oncol 2003;21:2026–2033.
   PubMed Web of Science ®Google Scholar
• Schwartz CL. Special issues in pediatric Hodgkin's disease. Eur J Haematol Suppl 2005;(66):55–62.
   PubMedGoogle Scholar
• Diehl V, Engert A, Re D. New strategies for the treatment of advanced-stage Hodgkin's lymphoma. Hematol Oncol Clin North Am 2007;21:897–914.
   PubMed Web of Science ®Google Scholar
• Bartlett NL. Modern treatment of Hodgkin lymphoma. Curr Opin Hematol 2008;15:408–414.
   PubMed Web of Science ®Google Scholar
• Evens AM, Hutchings M, Diehl V. Treatment of Hodgkin lymphoma: the past, present, and future. Nat Clin Pract Oncol 2008;5:543–556.
   PubMedGoogle Scholar
• Surveillance, Epidemiology and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence—SEER 17 Regs Limited-Use + Hurricane Katrina Impacted Louisiana Cases, Nov 2007 Sub (1973–2005 varying)—Linked To County Attributes—Total U.S., 1969–2005 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2008, based on the November 2007 submission .
   Google Scholar
• Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 1971;31:1860–1861.
   PubMed Web of Science ®Google Scholar
• Kapatai G, Murray P. Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma. J Clin Pathol 2007;60:1342–1349.
   PubMed Web of Science ®Google Scholar
• Meyer RM, Ambinder RF, Stroobants S. Hodgkin's lymphoma: evolving concepts with implications for practice. Hematology Am Soc Hematol Educ Program 2004:184–202.
   PubMedGoogle Scholar
• Franklin J, Paulus U, Lieberz D, Breuer K, Tesch H, Diehl V. Is the international prognostic score for advanced stage Hodgkin's disease applicable to early stage patients? Ann Oncol 2000;11:617–623.
   PubMed Web of Science ®Google Scholar
• Zaki A, Natarajan N, Mettlin CJ. Early and late survival in Hodgkin disease among whites and blacks living in the United States. Cancer 1993;72:602–606.
   PubMed Web of Science ®Google Scholar
• Metzger ML, Castellino SM, Hudson MM, et al. Effect of race on the outcome of pediatric patients with Hodgkin's lymphoma. J Clin Oncol 2008;26:1282–1288.
   PubMed Web of Science ®Google Scholar
• Smith RS, Chen Q, Hudson MM, et al. Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy. J Clin Oncol 2003;21:2026–2033.
   PubMed Web of Science ®Google Scholar
• Connors JM, Noordijk EM, Horning SJ. Hodgkin's lymphoma: basing the treatment on the evidence. Hematology Am Soc Hematol Educ Program 2001;178–193.
   PubMedGoogle Scholar
• Carde P, Hagenbeek A, Hayat M, et al. Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group. J Clin Oncol 1993;11:2258–2272.
   PubMed Web of Science ®Google Scholar
• Specht L, Gray RG, Clarke MJ, Peto R. Influence of more extensive radiotherapy and adjuvant chemotherapy on long-term outcome of early-stage Hodgkin's disease: a meta-analysis of 23 randomized trials involving 3,888 patients. International Hodgkin's Disease Collaborative Group. J Clin Oncol 1998;16:830–843.
   PubMed Web of Science ®Google Scholar
• Edwards-Bennett SM, Jacks LM, Moskowitz CH, et al. Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experience. Ann Oncol 2010;21:574–581.
   PubMed Web of Science ®Google Scholar
• Niitsu N, Okamoto M, Tomita N, et al. Multicentre phase II study of the baseline BEACOPP regimen for patients with advanced-stage Hodgkin's lymphoma. Leuk Lymphoma 2006;47:1908–1914.
   PubMed Web of Science ®Google Scholar
• Diehl V, Franklin J, Pfreundschuh M, et al. Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease. N Engl J Med 2003;348:2386–2395.
   PubMed Web of Science ®Google Scholar
• Juweid ME. Utility of positron emission tomography (PET) scanning in managing patients with Hodgkin lymphoma. Hematology Am Soc Hematol Educ Program 2006:259–265, 510–511.
   PubMedGoogle Scholar
• Furth C, Steffen IG, Amthauer H, et al. Early and late therapy response assessment with [18F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin's lymphoma: analysis of a prospective multicenter trial. J Clin Oncol 2009;27:4385–4391.
   PubMed Web of Science ®Google Scholar
• Bar Ad V, Paltiel O, Glatstein E. Radiotherapy for early-stage Hodgkin's lymphoma: a 21st century perspective and review of multiple randomized clinical trials. Int J Radiat Oncol Biol Phys 2008;72:1472–1479.
   PubMed Web of Science ®Google Scholar
• Hudson MM. Pediatric Hodgkin's therapy: time for a paradigm shift. J Clin Oncol 2002;20:3755.
   PubMed Web of Science ®Google Scholar
• Nachman JB, Sposto R, Herzog P, .;et al. Children's Cancer Group. Randomized comparison of low-dose involved field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy. J Clin Oncol 2002;20:3765–3771.
   PubMed Web of Science ®Google Scholar
• Glaser SL, Dorfman RF, Clarke CA. Expert review of the diagnosis and histologic classification of Hodgkin disease in a population-based cancer registry. Cancer 2001;92:218–224.
   PubMed Web of Science ®Google Scholar